Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)
China flag China · Delayed Price · Currency is CNY
24.66
+0.08 (0.33%)
Feb 13, 2026, 3:00 PM CST

SHA:688298 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
2,4313,0814,1656,5976,0982,039
Short-Term Investments
----31.15-
Trading Asset Securities
211.69207.581,0521,161168.07199
Cash & Short-Term Investments
2,6433,2895,2177,7586,2972,238
Cash Growth
-28.70%-36.95%-32.75%23.19%181.43%2519.03%
Accounts Receivable
226.66230.17207.74309.361,184625.82
Other Receivables
10.4419.1220.773.1353.9643.83
Receivables
237.11249.28228.44382.491,238669.65
Inventory
332.05308.96346.78431.92470.56381.58
Other Current Assets
153.96131.45104.01175.42120.0630.5
Total Current Assets
3,3663,9795,8968,7478,1263,319
Property, Plant & Equipment
2,8272,7412,2611,074481.34162.39
Long-Term Investments
48.5250.2752.3535.5925.45-
Goodwill
----15.41-
Other Intangible Assets
930.15690.91478.81481.24111.4814.13
Long-Term Deferred Tax Assets
272.74268.47218.26193.2369.6845.46
Long-Term Deferred Charges
47.8859.7161.0536.327.375.08
Other Long-Term Assets
15.43305.8528.05135.63139.8126.82
Total Assets
7,5088,0958,99610,7048,9773,573
Accounts Payable
479.04515.49600.491,5801,174371.97
Accrued Expenses
41.9772.0368.45218.81175.5597.64
Short-Term Debt
103.26116.78198.22---
Current Portion of Long-Term Debt
-300.2250.3---
Current Portion of Leases
15.1124.615.863.555.84-
Current Income Taxes Payable
6.23.413.7717.67606.85309.31
Current Unearned Revenue
33.2530.9934.77339.1471.19325.7
Other Current Liabilities
107.74140.29113.93119.2425.48.38
Total Current Liabilities
786.581,2041,0862,2782,0591,113
Long-Term Debt
159.09-30050--
Long-Term Leases
28.9447.1743.9628.6512.65-
Long-Term Unearned Revenue
34.2334.4810.7517.4617.018.8
Long-Term Deferred Tax Liabilities
0.050.230.042.76--
Other Long-Term Liabilities
6.0217.475.73.39--
Total Liabilities
1,0151,3031,4462,3812,0881,122
Common Stock
201.6201.6201.6168120120
Additional Paid-In Capital
397.89397.89395.42436.32549.21549.21
Retained Earnings
6,0556,2686,7977,5306,2011,785
Treasury Stock
-326.94-276.95----
Comprehensive Income & Other
33.1154.942.3728.27-12.72-7.76
Total Common Equity
6,3616,6457,4368,1636,8572,446
Minority Interest
132.14146.34113.66160.1531.625.37
Shareholders' Equity
6,4936,7917,5508,3236,8892,451
Total Liabilities & Equity
7,5088,0958,99610,7048,9773,573
Total Debt
306.41488.76608.3382.218.49-
Net Cash (Debt)
2,3362,8004,6097,6756,2792,238
Net Cash Growth
-25.66%-39.24%-39.95%22.24%180.61%3729.37%
Net Cash Per Share
12.1214.2422.8438.0831.1411.34
Filing Date Shares Outstanding
191.58193.2201.6201.6201.6201.6
Total Common Shares Outstanding
191.58193.2201.6201.6201.6201.6
Working Capital
2,5792,7754,8106,4696,0682,206
Book Value Per Share
33.2034.4036.8940.4934.0112.13
Tangible Book Value
5,4315,9546,9577,6826,7302,432
Tangible Book Value Per Share
28.3530.8234.5138.1033.3812.06
Buildings
-1,4651,296586.6243.6193.73
Machinery
-437.85360.52262.56177.0338.6
Construction In Progress
-1,134796.48369.99112.4570.29
Source: S&P Global Market Intelligence. Standard template. Financial Sources.